Pacific Edge signs Cxbladder agreement with MultiPlan

Pacific Edge signs Cxbladder agreement with national
provider network MultiPlan in the US

Pacific Edge
announced today that it has entered into a contractual
agreement with MultiPlan, Inc. for diagnostics laboratory
testing. The agreement includes Pacific Edge’s
participation in the MultiPlan, PHCS and PHCS Savility
Networks.

The agreement is the fourth signed with national
provider networks by Pacific Edge since October 2013 and is
another step in the Company’s commercial roll-out of
Cxbladder in the United States, the world’s largest
healthcare market. The agreement with MultiPlan in addition
to the agreements with FedMed, Americas Choice Provider
Network, and Stratose makes Cxbladder available to a
significant proportion of US residents.

Pacific Edge
Chief Executive Officer David Darling says national and
regional provider networks are a key component in the
commercial fabric ensuring that healthcare providers and
technology suppliers are paid by healthcare payers for
treatment provided to patients.

“Our participation in
these networks will give a large number of Americans access
to Cxbladder and its positive benefits as a quick, cost
effective, non-invasive and highly accurate cancer detection
test that is particularly appealing to US healthcare
professionals, patients, and insurers.”

Pacific Edge’s
agreement with MultiPlan will give MultiPlan’s
participating providers and its clients’ members access to
Cxbladder. Approximately 900,000 providers participate in
MultiPlan’s provider networks and an estimated 68 million
consumers have access to one or more of these
networks.

Pacific Edge through its wholly owned subsidiary
Pacific Edge Diagnostics USA (PEDUSA) has launched Cxbladder
in the US and is processing samples collected using its
proprietary Urine Sampling System at its custom built, CAP
accredited laboratory in Hershey, Pennsylvania.

“Our
sales and marketing teams are now focussed on the urologists
and clinicians who are treating the largest number of
bladder cancer patients to ensure they fully understand the
value and benefits that Cxbladder provides to them and their
patients” says Jackie Walker, Chief Executive Officer of
PEDUSA.

“In addition we are advancing relationships with
large commercial payers and the Centre for Medicare and
Medicaid Services (CMS), which provides healthcare insurance
for 100 million people or nearly a third of the American
population. Progress is being made with key customer
segments including Integrated Healthcare Systems, the
Veterans Administration (VA), and Large Urology Groups
(LUGS),

who are the point of contact for many patients
presenting with haematuria blood in the urine) which is an
early indicator of possible bladder cancer.”

More than
one million Americans a year undergo medical investigation
for potential bladder cancer at an estimated cost in excess
of US$1 billion. Bladder cancer is one of the most expensive
cancers to treat.

The very high recurrence rate of this
disease, requiring some patients to receive expensive
monitoring for the rest of their lives, causes bladder
cancer to have the highest total medical costs of any cancer
from detection to death. In the US, the total medical cost
approaches US$220,000 per
patient.

Prime Minister John Key says it is “not the government’s preferred option” to make a fresh capital injection into the troubled state-owned coal miner, Solid Energy, but dodged journalists’ questions at his weekly press conference on whether that might prove necessary... More>>

NZCU Baywide says that once it was found to have committed a breach of a former staff member’s privacy, it had attempted to resolve the matter... the censure and remedies for its actions taken almost three years ago are “severe” but accepted, and will hopefully draw a line under the matter. More>>

PayPal has ceased processing payments for Mega, the file storage and encryption firm looking to join the New Zealand stock market via a reverse listing of TRS Investments, amid claims it is not a legitimate cloud storage service. More>>

The New Zealand government's operating deficit was smaller than expected in the first six months of the financial year, as the consumption and corporate tax take rose ahead of forecast in December, having lagged estimates in previous months. More>>